These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 15676065)

  • 1. Mutagenicity testing with transgenic mice. Part II: Comparison with the mouse spot test.
    Wahnschaffe U; Bitsch A; Kielhorn J; Mangelsdorf I
    J Carcinog; 2005 Jan; 4(1):4. PubMed ID: 15676065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutagenicity testing with transgenic mice. Part I: Comparison with the mouse bone marrow micronucleus test.
    Wahnschaffe U; Bitsch A; Kielhorn J; Mangelsdorf I
    J Carcinog; 2005 Jan; 4(1):3. PubMed ID: 15655069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lacI transgenic mouse mutagenicity assay: quantitative evaluation in comparison to tests for carcinogenicity and cytogenetic damage in vivo.
    Shephard SE; Lutz WK; Schlatter C
    Mutat Res; 1994 Apr; 306(2):119-28. PubMed ID: 7512210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying in vivo somatic mutations using transgenic mouse model systems.
    Swiger RR
    Methods Mol Biol; 2014; 1105():271-82. PubMed ID: 24623235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation-induced point mutations, deletions and micronuclei in lacI transgenic mice.
    Winegar RA; Lutze LH; Hamer JD; O'Loughlin KG; Mirsalis JC
    Mutat Res; 1994 Jun; 307(2):479-87. PubMed ID: 7514721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic mouse mutation assay systems can play an important role in regulatory mutagenicity testing in vivo for the detection of site-of-contact mutagens.
    Dean SW; Brooks TM; Burlinson B; Mirsalis J; Myhr B; Recio L; Thybaud V
    Mutagenesis; 1999 Jan; 14(1):141-51. PubMed ID: 10474836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of the Muta mouse lacZ/galE- transgenic mutation assay to DMN: comparisons with the corresponding Big Blue (lacI) responses.
    Tinwell H; Lefevre PA; Ashby J
    Mutat Res; 1994 May; 307(1):169-73. PubMed ID: 7513794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genetic analysis of lacI mutations in sectored plaques from Big Blue transgenic mice.
    Stuart GR; Gorelick NJ; Andrews JL; de Boer JG; Glickman BW
    Environ Mol Mutagen; 1996; 28(4):385-92. PubMed ID: 8991067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of Muta™Mouse λgt10-lacZ transgene: evidence for in vivo rearrangements.
    Shwed PS; Crosthwait J; Douglas GR; Seligy VL
    Mutagenesis; 2010 Nov; 25(6):609-16. PubMed ID: 20724577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
    Recio L; Saranko CJ; Steen AM
    Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of in vivo mutagenicity of hydroquinone in Muta™ mice.
    Matsumoto M; Masumori S; Hirata-Koizumi M; Ono A; Honma M; Yokoyama K; Hirose A
    Mutat Res Genet Toxicol Environ Mutagen; 2014 Dec; 775-776():94-8. PubMed ID: 25435360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
    Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
    Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preliminary evaluation of the performance of the Muta Mouse (lacZ) and Big Blue (lacI) transgenic mouse mutation assays.
    Morrison V; Ashby J
    Mutagenesis; 1994 Jul; 9(4):367-75. PubMed ID: 7968580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous mutations in the Big Blue transgenic system are primarily mouse derived.
    Hill KA; Buettner VL; Glickman BW; Sommer SS
    Mutat Res; 1999 Jan; 436(1):11-9. PubMed ID: 9878678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward an understanding of the use of transgenic mice for the detection of gene mutations in germ cells.
    Douglas GR; Gingerich JD; Soper LM; Jiao J
    Mutat Res; 1997 Feb; 388(2-3):197-212. PubMed ID: 9057881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantifying in vivo somatic mutations using transgenic mouse model systems.
    Swiger RR
    Methods Mol Biol; 2005; 291():145-53. PubMed ID: 15502219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice.
    Kohler SW; Provost GS; Fieck A; Kretz PL; Bullock WO; Sorge JA; Putman DL; Short JM
    Proc Natl Acad Sci U S A; 1991 Sep; 88(18):7958-62. PubMed ID: 1832771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
    Battershill JM; Fielder RJ
    Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a lambda-based complementation assay for the preliminary localization of lacI mutants from the Big Blue mouse: implications for a DNA-sequencing strategy.
    Gu M; Ahmed A; Wei C; Gorelick N; Glickman BW
    Mutat Res; 1994 Jun; 307(2):533-40. PubMed ID: 7514727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of lacI and lacZ transgenic mouse mutation assays: an EU-sponsored interlaboratory study.
    Tinwell H; Liegibel U; Krebs O; Schmezer P; Favor J; Ashby J
    Mutat Res; 1995 Oct; 335(2):185-90. PubMed ID: 7477049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.